BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Telesair Secures Strategic OUS License Agreement for Next Generation Respiratory Technology

  Telesair, Inc., an innovator of next generation respiratory care, announced today that it has closed a license agreement with a leading global medical device manufacturer.

  June 28, 2022

   · 

  2 min read
• Saama Technologies Announces Appointment of New CEO Vivek Sharma

  Saama Technologies, LLC. (“Saama”) today announced that Vivek Sharma has joined the company as Chief Executive Officer (CEO).

  June 28, 2022

   · 

  3 min read
• U.S. Behavioral Health Care Software and Services Market Size, Report 2022-2030

  The U.S. behavioral health care software and services market was surpassed at USD 1.2 billion in 2021 and is expected to hit around USD 3.3 billion by 2030, growing at a CAGR of 11.9% from 2022 to 2030.

  June 28, 2022

   · 

  7 min read
• Transdermal Patch Market Size to Hit US$ 8726.9 Million by 2028

  The global Transdermal Patch market size is estimated to be worth US$ 6793 million in 2021 and is forecast to a readjusted size of US$ 8726.9 million by 2028 with a CAGR of 3.6% during the forecast period 2022-2030.

  June 28, 2022

   · 

  4 min read
• Newcastle Disease Vaccine Market Size to Hit US$ 396.2 Million by 2028

  The global Newcastle Disease Vaccine market size is estimated to be worth US$ 314.8 million in 2021 and is forecast to a readjusted size of US$ 396.2 million by 2028 with a CAGR of 3.3% during the forecast period 2022-2030.

  June 28, 2022

   · 

  4 min read
• Hydroxycarbamide Market Size, Growth, Trends, Report 2022-2030

  The global Hydroxycarbamide market size is estimated to be worth US$ 233 million in 2021 and is forecast to a readjusted size of US$ 342.7 million by 2028 with a CAGR of 5.6% during the forecast period 2022-2030.

  June 28, 2022

   · 

  4 min read
• U.S. Tissue Diagnostics Market Size to Hit US$ 4.51 Billion by 2030

  The U.S. Tissue Diagnostics market size was valued at US$ 2.77 billion in 2021 and is expected to hit US$ 4.51 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.11% from 2022 to 2030..

  June 28, 2022

   · 

  10 min read
• U.S. Behavioral Health Care Software and Services Market Size to Hit US$ 6.2 billion by 2030

  According to Nova one advisor, the U.S. Behavioral Health Care Software And Services market size was valued at US$ 1.98 Billion in 2021 and is expected to hit US$ 6.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 16.1 % from 2022 to 2030.

  June 28, 2022

   · 

  8 min read
• Long Read Sequencing Market to Garner USD 2514.06 million by 2029 With Comprehensive Analysis, Key Trends And Industry Segmentation

  Long Read Sequencing market report examines market drivers, market restraints, challenges, opportunities and key developments in the Long Read Sequencing industry.

  June 28, 2022

   · 

  10 min read
• 4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq

  4D pharma plc announces that on June 27, 2022, it received written notice from The Nasdaq Stock Market LLC stating that in accordance with Listing Rules 5101, 5110, and IM-5101-1, Nasdaq Staff has determined that 4D pharma’s securities will be delisted from The Nasdaq Stock Market.

  June 28, 2022

   · 

  4 min read